Related Experiment Videos
Membrane origin for a signal eliciting a program of cell differentiation
Experimental Cell Research
|June 1, 1984
Summary
Retinoic acid (RA) triggers myeloid cell differentiation and growth arrest via a cell membrane signal. This occurs even when RA is immobilized, explaining responses in cells lacking cellular RA-binding protein (CRABP).
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- HL-60 human promyelocytic leukemia cells undergo myeloid differentiation and growth arrest in response to retinoic acid (RA).
- The precise initiation mechanism and location of the RA signaling pathway in these cells remain under investigation.
- The role of cellular RA-binding protein (CRABP) in mediating RA responses is a key area of study.
Purpose of the Study:
- To investigate the initial signaling event for retinoic acid (RA)-induced differentiation and growth arrest in HL-60 cells.
- To determine if the cell membrane is the site of initiation for RA signaling.
- To elucidate the mechanism by which CRABP-deficient HL-60 cells respond to RA.
Main Methods:
- Utilizing HL-60 human promyelocytic leukemia cells.
- Comparing the effects of free RA with RA covalently immobilized on a solid substrate.
- Analyzing the kinetics of myeloid differentiation and G1/0-specific growth arrest.
- Assessing for RA detachment from the solid substrate by the cells.
Main Results:
- Retinoic acid (RA) induced myeloid differentiation and G1/0-specific growth arrest in HL-60 cells.
- Both free RA and substrate-bound RA elicited similar response kinetics.
- No evidence suggested that HL-60 cells detached RA from the solid substrate.
- The findings were consistent in CRABP-deficient HL-60 cells.
Conclusions:
- The RA-induced program of myeloid differentiation and growth arrest in HL-60 cells is initiated by a signal originating at the cell membrane.
- Cellular RA-binding protein (CRABP) is not essential for HL-60 cells to initiate the response to RA.
- These findings provide a mechanistic explanation for RA responsiveness in CRABP-deficient leukemia cells.